AstraZeneca Pharma
BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Pharmaceuticals
- Directors Report
- Chairman's Speech
- Auditors Report
- Notes To Accounts
- Accounting Policy
- Finished Products
- Raw Materials
| Auditor's Report | Year End : Dec '08 |
We have audited the attached balance sheet of AstraZeneca Pharma India
Limited (the Company) as at 31 December 2008, the profit and loss
account and the cash flow statement for the year ended on that date
annexed thereto. These financial statements are the responsibility of
the Companys management. Our responsibility is to express an opinion
on these financial statements based on our audit.
We conducted our audit in accordance with Auditing Standards generally
accepted in India. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made
by management, as well as evaluating the overall financial statement
presentation. We believe that our audit provides a reasonable basis for
our opinion.
As required by the Companies (Auditors Report) Order, 2003, as
amended, issued by the Central Government of India in terms of
sub-section (4A) of Section 227 of the Companies Act, 1956, we enclose
in the Annexure a statement on the matters specified in paragraphs 4
and 5 of the said Order.
Further to our comments in the Annexure referred to above, we report
that:
(i) we have obtained all the information and explanations, which to the
best of our knowledge and belief were necessary for the purpose of our
audit;
(ii) in our opinion, proper books of account as required by law have
been kept by the Company so far as appears from our examination of
those books;
(iii) the balance sheet, the profit and loss account and the cash flow
statement dealt with by this report are in agreement with the books of
account;
(iv) in our opinion, the balance sheet, the profit and loss account and
the cash flow statement dealt with by this report comply with the
Accounting Standards referred to in sub-section (3C) of Section 211 of
the Companies Act, 1956;
(v) on the basis of written representations received from the directors
of the Company as on 31 December 2008, and taken on record by the Board
of Directors, we report that none of the directors is disqualified as
on 31 December 2008 from being appointed as a director in terms of
clause (g) of sub-section (1) of Section 274 of the Companies Act,
1956; and
(vi) in our opinion and to the best of our information and according to
the explanations given to us, the said accounts give the information
required by the Companies Act, 1956, in the manner so required and give
a true and fair view in conformity with the accounting principles
generally accepted in India:
a. in the case of the balance sheet, of the state of affairs of the
Company as at 31 December 2008;
b. in the case of the profit and loss account, of the profit of the
Company for the year ended on that date; and
c. in the case of the cash flow statement, of the cash flows for the
year ended on that date.
Annexure to the Auditors Report
Annexure referred to in the Auditors Report to the Members of
AstraZeneca Pharma India Limited (the Company) for the year ended 31
December 2008. We report that:
(i) (a) The Company has maintained proper records showing full
particulars, including quantitative details and situation of its fixed
assets.
(b) The Company has a regular programme of physical verification of its
fixed assets by which all fixed assets are verified in a phased manner
over a period of three years. In our opinion, this periodicity of
physical verification is reasonable having regard to the size of the
Company and the nature of its assets, in accordance with this
programme, certain fixed assets were verified during the year. No
material discrepancies were noticed on such verification.
(c) Fixed assets disposed off during the year were not substantial, and
therefore, do not affect the going concern assumption.
(ii) (a) The inventory, except stock lying with third parties, has been
physically verified by the management during the year. In our opinion,
the frequency of such verification is reasonable. For stocks lying with
third parties at the year-end, written confirmations have been
obtained.
(b) The procedures for the physical verification of inventories
followed by the management are reasonable and adequate in relation to
the size of the Company and the nature of its business.
(c) The Company is maintaining proper records of inventory. The
discrepancies noticed on verification between the physical stocks and
the book records were not material.
(iii) The Company has neither granted nor taken any loans, secured or
unsecured, to or from companies, firms or other parties covered in the
register maintained under section 301 of the Companies Act, 1956.
(iv) In our opinion and according to the information and explanations
given to us, and having regards to the explanation that purchases of
certain items of inventory are for the Companys specialised
requirements and similarly certain goods sold are for specialised
requirements of the buyer and suitable alternative sources are not
available to obtain comparable quotations, there is an adequate
internal control system commensurate with the size of the Company and
the nature of its business with regard to purchase of inventories and
fixed assets and with regard to the sale of goods and services. We have
not observed any major weakness in the internal control system during
the course of the audit.
(v) (a) In our opinion and according to the information and
explanations given to us, the particulars of contracts or arrangements
referred to in Section 301 of the Companies Act, 1956 have been entered
in the register required to be maintained under that section.
(b) In our opinion and according to the information and explanations
given to us, the transactions made in pursuance of such contracts and
arrangements referred to in (a) above and exceeding the value of Rs 5
lakh with any party during the year have been made at prices which are
reasonable having regard to the prevailing market prices at the
relevant time.
(vi) The Company has not accepted any deposits from the public.
(vii) In our opinion, the Company has an internal audit system
commensurate with the size and nature of its business.
(viii) We have broadly reviewed the books of account maintained by the
Company pursuant to the rules prescribed by the Central Government for
maintenance of cost records under Section 209(1 )(d) of the Companies
Act, 1956 in respect of bulk drugs and formulations and are of the
opinion that prima facie, the prescribed accounts and records have been
made and maintained. However, we have not made a detailed examination
of the records.
(ix) (a) According to the information and explanation given to us and
on the basis of our examination of the records of the Company, amounts
deducted/accrued in the books of account in respect of undisputed
statutory dues including Provident Fund, Employees State Insurance,
Investor Education and Protection Fund, Income-tax, Wealth Tax,
Service Tax, Customs Duty, Excise Duty, Cess and other material
statutory dues, except for sales tax as mentioned below, have
generally been regularly deposited with the appropriate authorities
though there has been a slight delay in a few cases.
Further, since the Central Government has till date not prescribed the
amount of cess payable under section 441A of the Companies Act, 1956,
we are not in a position to comment upon the regularity or otherwise of
the Company in depositing the same.
According to the information and explanations given to us, except for
sales tax dues aggregating to Rs. 765,290/-, no undisputed amounts
payable in respect of Provident Fund, Employees State Insurance,
Investor Education and Protection Fund, Income-tax, Wealth Tax, Service
Tax, Customs Duty, Excise Duty, Cess and other material statutory dues
were in arrears as at 31 December 2008 for a period of more than six
months from the date they became payable.
(b) According to the information and explanations given to us, there
are no dues of Income-tax, Wealth Tax and Cess which have not been
deposited with the appropriate authorities on account of any dispute.
According to the information and explanations given to us, the
following dues of Sales tax, Customs Duty, Excise Duty and Service Tax,
have not been deposited by the Company on account of disputes:
Name of the Nature of
Statute the dues Amount(Rs)
Central Excise Excise duty 698,427
Act, 1944
Chapter V of Service tax 47,712
Finance Act,
1994
Chapter V of Service tax 543,460
Finance Act,
1994
Central Excise Excise duty 406,677
Act, 1944
Kamataka Sales tax 9,251,712
Sales Tax and penalty
Act, 1957
Karnataka Entry tax 91,224
Sales Tax
Act, 1957
Customs Act, Customs 21,248,482
1962 duty
Period to which the Forum where dispute is
amountrelates pending
1996-1997 to Customs Excise and
1999-2000 Service tax Appellate
tribunal
1 July 2001 to Deputy Commissioner,
15 August 2002 Service tax
16 November 1997 Commissionrate - Service
to 2 June 1998 Tax
August 1998 to July Customs Excise and
1999 Service Tax Appellate
Tribunal
1995 -1996 Karnataka Appellate
Tribunal
1995 - 1996 Joint Commissioner of
Commercial Taxes
(Appeals)
2006 Deputy Commissioner,
Customs, Mumbai
(x) The Company does not have any accumulated losses at the end of the
financial year and has not incurred cash losses in the financial year
and in the immediately preceding financial year.
(xi) The Company did not have any outstanding dues to any financial
institution, banks or debenture holders during the year.
(xii) The Company has not granted any loans and advances on the basis
of security by way of pledge of shares, debentures and other
securities.
(xiii) In our opinion and according to the information and explanation
given to us, the Company is not a chit fund/ nidhi / mutual benefit
fund / society.
(xiv) According to the information and explanations given to us, the
Company is not dealing or trading in shares, securities, debentures and
other investments.
(xv) According to the information and explanations given to us, the
Company has not given any guarantee for loans taken by others from
banks or financial institutions.
(xvi) The Company did not have any term loans outstanding during the
year.
(xvii) According to the information and explanations given to us and on
an overall examination of the balance sheet of the Company, we are of
the opinion that the funds raised on short-term basis have not been
used for long- term investment.
(xviii) The Company has not made any preferential allotment of shares
to companies/firms/parties covered in the register maintained under
Section 301 of the Companies Act, 1956.
(xix) According to the information and explanations given to us, the
Company has created a charge in respect of debentures issued during the
year.
(xx) The Company has not raised any money by public issues during the
year.
(xxi) We have been informed that an employee of one of the carrying and
forwarding agents of the Company was fraudulently crediting the
collections received from a few of the Companys customers towards
outstanding dues from a specific customer. This was done in a manner
such that the outstanding of any of the customers did not exceed the
credit period.
As explained to us, the Management has completed the investigation in
this matter and has accordingly recovered the outstanding amount of Rs
1,340,000 from the carrying and forwarding agent, thereby resulting in
no loss to the Company. According to the information and explanations
given to us, no other fraud on or by the Company has been noticed or
reported during the course of our audit.
for BSR & Co.
Chartered Accountants
Rajesh Arora
Partner
Membership No. 76124
Bangalore
Date: 18 February 2009
|
|
![]() | |
| Source : Religare Technova | |
![]() | |




Online










